Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

AMAG Pharmaceuticals Inc. (AMAG)

13.605   4.205 (44.73%) 10-01 15:34
Open: 12.98 Pre. Close: 9.4
High: 13.8 Low: 12.55
Volume: 28,437,030 Market Cap: 469M
AMAG Pharmaceuticals, Inc. is a biopharmaceutical company. The company is headquartered in Waltham, Massachusetts and currently employs 467 full-time employees. The firm's segment is the manufacture, development and commercialization of products and services for use in treating various conditions, with a focus on maternal health, anemia management and cancer supportive care. Its offerings focus on maternal health, anemia management and cancer supportive care, including its product, Makena (hydroxyprogesterone caproate injection); its product, Feraheme (ferumoxytol), for intravenous (IV) use, and MuGard Mucoadhesive Oral Wound Rinse. The company is engaged in the development of Digoxin immune fab, a polyclonal antibody for the treatment of severe preeclampsia in pregnant women. Makena is a drug indicated to reduce the risk of preterm birth in women pregnant with a single baby having a history of singleton spontaneous preterm birth.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 9.612 - 9.648 9.648 - 9.685
Low: 9.183 - 9.228 9.228 - 9.272
Close: 9.329 - 9.396 9.396 - 9.464

Technical analysis

as of: 2020-10-01 3:00:29 PM
Overall:       
Stoxline posted a STRONG BUY today, same as yesterday. Upward movement continues.
Target: Six months: 16.12     One year: 18.83
Support: Support1: 10.60    Support2: 8.62
Resistance: Resistance1: 13.80    Resistance2: 16.12
Pivot: 9.66
Moving Average: MA(5): 10.09     MA(20): 9.65
MA(100): 8.92     MA(250): 9.23
MACD: MACD(12,26): 0.17     Signal(9): -0.09
Stochastic oscillator: %K(14,3): 62.80     %D(3): 46.69
RSI: RSI(14): 77.04
52-week: High: 13.80  Low: 4.41  Change(%): 18.3
Average Vol(K): 3-Month: 89862  10-Days: 320034

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
AMAG has closed above the upper band by 39.6%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 113% wider than normal. The large width of the bands suggest high volatility as compared to AMAG's normal range. The bands have been in this wide range for 0 bars. This is a sign that the current trend might continue.

Headline News

Thu, 01 Oct 2020
Here is why AMAG Pharmaceuticals Inc. (AMAG) stock volatility recorded over the last month was 5.45% - The InvestChronicle

Thu, 01 Oct 2020
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) shares surges 1.56% in a week – but can it keep rising? - Marketing Sentinel

Thu, 01 Oct 2020
AMAG Pharmaceuticals Inc (AMAG) Q2 2020 Earnings Call Transcript - AlphaStreet

Thu, 01 Oct 2020
Is AMAG Pharmaceuticals Inc. (AMAG) a Keeper? - The News Heater

Thu, 01 Oct 2020
Covis Group Announces Agreement to Acquire AMAG Pharmaceuticals - GlobeNewswire

Thu, 01 Oct 2020
ROCE Insights For AMAG Pharmaceuticals - Yahoo Finance

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Neutral Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 34
Shares Float (M) 17
% Held by Insiders 1.74
% Held by Institutions 134.32
Shares Short (K) 10,670
Shares Short P. Month (K) 11,230

Stock Financials

EPS -7.600
EPS Est This Year -1.390
EPS Est Next Year -1.720
Book Value (p.s.) 7.230
Profit Margin -86.95
Operating Margin -30.85
Return on Assets (ttm) -6.6
Return on Equity (ttm) -69.1
Qtrly Rev. Growth -32.2
Gross Profit (p.s.) 5.154
Sales Per Share 8.634
EBITDA (p.s.) -2.146
Qtrly Earnings Growth
Operating Cash Flow (M) -73
Levered Free Cash Flow (M) -133

Stock Valuations

PE Ratio -1.79
PEG Ratio
Price to Book value 1.88
Price to Sales 1.58
Price to Cash Flow -6.45

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.